FDA Clearance Tracker · K233557
HemoCare Hemodialysis System
Last checked: Nov 20, 2026Latest source record: Jul 12, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Jul 12, 2024
Substantially Equivalent
Time to decision
249 days
Received Nov 6, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K233557
- Device name
- HemoCare Hemodialysis System
- Applicant
- Deka Research and Development
- Applicant location
- Manchester, NH
- Received
- Nov 6, 2023
- Decided
- Jul 12, 2024
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 876.5860
- Specialty
- GI, Urology & NephrologyNephrology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code KDI. The earliest in FDA's data is K780527, decided Dec 20, 1978.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K233557
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Deka Research and Development
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- twiist Loop Algorithm510(k)
K262576 · Decided Oct 15, 2026 · 80 days after receipt
Device type: Interoperable Automated Glycemic Controller (QJI) · Laboratory Medicine & Pathology
K261672 · Decided Jun 17, 2026 · 27 days after receipt
Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG) · Laboratory Medicine & Pathology
- iiSure Infusion Set510(k)
K261530 · Decided Jun 3, 2026 · 26 days after receipt
Device type: Set, Administration, Intravascular (FPA) · Hospital Medicine & Nursing
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.